Raymond James & Associates’s Angi Inc ANGI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-3,490
Closed -$198K 4025
2022
Q1
$198K Sell
3,490
-842
-19% -$61.4K ﹤0.01% 3671
2021
Q4
$399K Sell
4,332
-6,990
-62% -$756K ﹤0.01% 3256
2021
Q3
$1.4M Buy
11,322
+1,894
+20% +$218K ﹤0.01% 2357
2021
Q2
$1.27M Buy
9,428
+1,530
+19% +$222K ﹤0.01% 2422
2021
Q1
$1.03M Buy
7,898
+2,911
+58% +$422K ﹤0.01% 2493
2020
Q4
$658K Buy
+4,987
New +$579K ﹤0.01% 2623
2020
Q3
Sell
-3,229
Closed -$392K 3588
2020
Q2
$392K Buy
3,229
+99
+3% +$9.02K ﹤0.01% 2763
2020
Q1
$164K Buy
+3,130
New +$233K ﹤0.01% 3103
2019
Q2
Sell
-1,943
Closed -$300K 3635
2019
Q1
$300K Buy
+1,943
New +$315K ﹤0.01% 2978
2017
Q1
Sell
-1,168
Closed -$96K 3293
2016
Q4
$96K Sell
1,168
-90
-7% -$7.67K ﹤0.01% 3033
2016
Q3
$125K Buy
+1,258
New +$110K ﹤0.01% 2961
2016
Q2
Sell
-1,985
Closed -$160K 3017
2016
Q1
$160K Sell
1,985
-5,591
-74% -$483K ﹤0.01% 2629
2015
Q4
$708K Sell
7,576
-4,707
-38% -$393K ﹤0.01% 1818
2015
Q3
$619K Buy
12,283
+7,513
+158% +$383K ﹤0.01% 1838
2015
Q2
$294K Buy
+4,770
New +$293K ﹤0.01% 2286

Other funds holding ANGI

Raymond James & Associates's ANGI Position: Q2 2022 in Review

Raymond James & Associates sold out of Angi Inc (ANGI) in Q2 2022, closing a stake of 3,490 shares — an estimated $198K sold.

Raymond James & Associates first reported a position in ANGI in Q2 2015 and held it in 15 quarters. The position peaked at $1.4M in Q3 2021. 128 funds tracked by Wall St. Rank hold ANGI as of Q2 2022.

  • Raymond James & Associates reported no remaining Angi Inc position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 3,490 Angi Inc shares in Q2 2022, an estimated $198K.
  • Raymond James & Associates first reported a position in Angi Inc in Q2 2015 and held it in 15 quarters.
  • Raymond James & Associates's Angi Inc position peaked at $1.4M in Q3 2021.
  • 128 funds tracked by Wall St. Rank held Angi Inc as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.